Rapid genome editing by CRISPR-Cas9-POLD3 fusion.
Ganna ReintZhuokun LiKornel LabunSalla KeskitaloInkeri SoppaKatariina MamiaEero ToloMonika SzymanskaLeonardo A Meza-ZepedaSusanne LorenzArtur Cieslar-PobudaXian HuDiana L BordinJudith StaerkEivind ValenBernhard SchmiererMarkku VarjosaloJussi TaipaleEmma HaapaniemiPublished in: eLife (2021)
Precision CRISPR gene editing relies on the cellular homology-directed DNA repair (HDR) to introduce custom DNA sequences to target sites. The HDR editing efficiency varies between cell types and genomic sites, and the sources of this variation are incompletely understood. Here, we have studied the effect of 450 DNA repair protein-Cas9 fusions on CRISPR genome editing outcomes. We find the majority of fusions to improve precision genome editing only modestly in a locus- and cell-type specific manner. We identify Cas9-POLD3 fusion that enhances editing by speeding up the initiation of DNA repair. We conclude that while DNA repair protein fusions to Cas9 can improve HDR CRISPR editing, most need to be optimized to the cell type and genomic site, highlighting the diversity of factors contributing to locus-specific genome editing outcomes.
Keyphrases
- dna repair
- crispr cas
- genome editing
- dna damage
- dna damage response
- copy number
- protein protein
- single cell
- type diabetes
- amino acid
- genome wide association study
- circulating tumor
- drinking water
- oxidative stress
- cell therapy
- mesenchymal stem cells
- metabolic syndrome
- small molecule
- bone marrow
- dna methylation
- nucleic acid